Bajaj Healthcare zooms after USFDA completes pre-approval inspection at API facility in Gujarat

18 Nov 2022 Evaluate

Bajaj Healthcare is currently trading at Rs. 403.25, up by 9.90 points or 2.52% from its previous closing of Rs. 393.35 on the BSE.

The scrip opened at Rs. 393.00 and has touched a high and low of Rs. 424.40 and Rs. 393.00 respectively. So far 21209 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 494.00 on 18-Jan-2022 and a 52 week low of Rs. 256.80 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 424.40 and Rs. 361.25 respectively. The current market cap of the company is Rs. 1112.91 crore.

The promoters holding in the company stood at 67.30%, while Institutions and Non-Institutions held 0.09% and 32.61% respectively.

United State Food and Drug Administration (USFDA) has successfully completed pre-approval inspection at Bajaj Healthcare’s API facility located at Vadodara, Gujarat with ZERO 483 observation. USFDA has conducted pre- approval inspection of its API facility from November 14, 2022 to November 17, 2022.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

290.00 -1.50 (-0.51%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.